Catalent (CTLT)
(Delayed Data from NYSE)
$54.82 USD
+0.17 (0.31%)
Updated May 24, 2024 04:00 PM ET
After-Market: $54.78 -0.04 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Catalent, Inc. [CTLT]
Reports for Purchase
Showing records 161 - 180 ( 215 total )
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS